Lawrence Carter

Lawrence (Larry) Carter, PhD is Vice President, Clinical Development at Alector, where he is working to develop new therapies for FTD and ALS. Throughout his career, Larry has worked across academic, industry, and government settings, including as VP of R&D at Alexza Pharmaceuticals where he led drug-device combination development programs in rare diseases, and as an Executive Director, Clinical Development at Jazz Pharmaceuticals where he led the global development program for Sunosi®, resulting in approvals for multiple indications in the US, EU, and Canada. Larry has served as a Special Government Employee to FDA and serves as an Adjunct Assistant Professor of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences. His training includes a PhD in Pharmacology from the University of Texas Health Sciences Center at San Antonio and a postdoctoral clinical research fellowship in the Department of Psychiatry at Johns Hopkins University School of Medicine.

Posts by Lawrence Carter